MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 514-520

  Li, Sufang ^a   Chen, Hong ^a   Ren, Jingyi ^a   Geng, Qiang ^a   Song, Junxian ^a   Lee, Chongyou ^a   Cao, Chengfu ^a   Zhang, Jing ^a   Xu, Ning ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atherosclerosis; MicroRNA 223; Thrombogenesis; Tissue factor; TNF

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 223; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOINFORMATICS; BLOOD CLOTTING; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84908504015     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.09.033     Document Type: Article

References (33)

1. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2045-2051.
2. Hopkins P.N. Molecular biology of atherosclerosis. Physiol. Rev. 2013, 93:1317-1542.
3. Eilertsen K.E., Østerud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul. Fibrinolysis 2004, 15:521-538.
4. Mandal S.K., Pendurthi U.R., Rao L.V. Cellular localization and trafficking of tissue factor. Blood 2006, 107:4746-4753.
5. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N.Engl. J. Med. 2013, 368:2004-2013.
6. Furie B., Furie B.C. Mechanisms of thrombus formation. N.Engl. J. Med. 2008, 359:938-949.
7. Bierhaus A., Zhang Y., Deng Y., et al. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J.Biol. Chem. 1995, 270:26419-26432.
8. Moll T., Czyz M., Holzmüller H., et al. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J.Biol. Chem. 1995, 270:3849-3857.
9. 2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2005-2011.
10. Li Y.D., Ye B.Q., Zheng S.X., et al. NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J.Biol. Chem. 2009, 284:4473-4483.
11. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
12. Pillai R.S., Bhattacharyya S.N., Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell. Biol. 2007, 17:118-126.
13. Santovito D., Mezzetti A., Cipollone F. MicroRNAs and atherosclerosis: new actors for an old movie. Nutr. Metab. Cardiovasc Dis. 2012, 22:937-943.
14. Taïbi F., Metzinger-Le Meuth V., M'Baya-Moutoula E., et al. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim. Biophys. Acta 2014, 1842:88-98.
15. Pan Y., Liang H., Liu H., et al. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J.Immunol. 2014, 192:437-446.
16. Maier W., Altwegg L.A., Corti R., et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid a but decreased C-reactive protein. Circulation 2005, 111:1355-1361.
17. Steffel J., Lüscher T.F., Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006, 113:722-731.
18. Menghini R., Stöhr R., Federici M. MicroRNAs in vascular aging and atherosclerosis. Ageing Res. Rev. 2014 Mar, 27. (Epub ahead of print).
19. Stellos K., Dimmeler S. Vascular microRNAs: from disease mechanisms to therapeutic targets. Circ. Res. 2014, 114:3-4.
20. Annex B.H., Denning S.M., Channon K.M., et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995, 91:619-622.
21. Cimmino G., D'Amico C., Vaccaro V., et al. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?. Expert Rev. Cardiovasc Ther. 2011, 9:517-523.
22. Teruel R., Pérez-Sánchez C., Corral J., et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J.Thromb. Haemost. 2011, 9:1985-1992.
23. Patel N., Tahara S.M., Malik P., Kalra V.K. Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placenta growth factor in human pulmonary endothelial cells. Biochem. J. 2011, 434:473-482.
24. Chen Z., Nakajima T., Tanabe N., et al. Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene. Hum. Genet. 2010, 128:443-452.
25. Shi L., Fisslthaler B., Zippel N., et al. MicroRNA-223 antagonizes angiogenesis by targeting β1 integrin and preventing growth factor signaling in endothelial cells. Circ. Res. 2013, 113:1320-1330.
26. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108:1664-1672.
27. Ren J., Zhang J., Xu N., et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One 2013, 8:e80738.
28. Chen Y.C., Bui A.V., Diesch J., et al. Anovel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ. Res. 2013, 113:252-265.
29. Haneklaus M., Gerlic M., Kurowska-Stolarska M., et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J.Immunol. 2012, 189:3795-3799.
30. Zampetaki A., Willeit P., Tilling L., et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J.Am. Coll. Cardiol. 2012, 60:290-299.
31. Chu A.J. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. Cell. Biochem. Funct. 2006, 24:173-192.
32. Cirillo P., Calì G., Golino P., et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 2004, 109:2911-2916.
33. Versteeg H.H., Spek C.A., Peppelenbosch M.P., Richel D.J. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol. Med. 2004, 10:6-11.